INDOUSIndo US Bio-Tech Ltd.

₹133.36-0.71%

Market Cap

₹266.69 Cr

Stock P/E

52.67

ROCE

15.46%

ROE

16.92%

Book Value

₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Public

Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Growth Outperformer

Indo US Bio-Tech Ltd. shows strong revenue growth and profitability, making it a standout in the agriculture sector. Although it has a moderate PE ratio, its growth metrics are attractive compared to peers. It is positioned well against its competitors, with significant potential for further gains.

Key Points

• Indo US Bio-Tech Ltd. has the highest revenue growth YoY at 24.8%.
• Kaveri Seed Company Ltd. leads in profitability with a high ROE of 20.67%.
• Venky'S (India) Ltd. is financially stressed with a high debt-to-equity ratio of 0.81.
• Bombay Burmah Trading Corporation Ltd. is overvalued with a PE ratio of 104.55.

Top Performers

Indo US Bio-Tech Ltd.

Highest revenue growth YoY at 24.8% and solid profitability metrics.

Kaveri Seed Company Ltd.

High ROE and strong margins indicate robust profitability.

Jubilant Agri And Consumer Products Ltd.

Strong ROCE and low debt levels enhance financial stability.

Explore

Watchlists

Command Palette